Skip to search formSkip to main contentSkip to account menu

COP-COPADM-VEM-VAD Regimen

Known as: HM89, HM89 Regimen, SFOP-HM89 Regimen 
A regimen administered in four phases that is used for the treatment of disseminated, childhood, anaplastic large cell lymphoma (ALCL). The 4 phases… 
National Institutes of Health

Related topics

Related topics

7 relations
Childhood Anaplastic Large Cell LymphomaCyclophosphamideDoxorubicinEtoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Liddy Shriver Sarcoma Initiative Targeted Therapies for Sarcomas : The Next Generation of Treatments
The recognition that some sarcomas are sensitive to chemotherapy has led to remarkable improvements in outcome for patients with… 
2008
2008
A study of 28 flat bone osteosarcomas: Prognostic factors, early and long-term outcome
10517 Background: Flat bone osteosarcoma (FBOS), arising in flat bones of the craniofacial region, axial skeleton, appendicular… 
2007
2007
[Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma].
BACKGROUND AND OBJECTIVE After the good results obtained by the Société Française d'Oncologie Pédiatrique (SFOP) regarding the… 
Review
2004
Review
2004
Bifocal Intracranial germinoma (BIG): Is there a place for localized radiation?
8548 BACKGROUND Bifocal tumours represent 7-12 % of primary cerebral germ cell tumours and are mostly germinomas. The treatment… 
1996
1996
13e réunion de la Société française d'oncologie pédiatrique-Psy (SFOP-Psy) Paris, 23 juin 1995 La décision thérapeutique en oncologie pediatrique
1995
1995
123 réunion SFOP-PSY, Paris 20 janvier 1995 Les fins de vie en oncologie pédiatrique
1992
1992
(Table 1) Age determination of sediment corew HM79-4 and HM89-6.2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)